Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New heart procedure trial aims to control dangerous rhythm in heart failure patients

NCT ID NCT07385417

Summary

This study is testing if a heart procedure is better than standard medication for managing atrial fibrillation (AFib) in people with a specific type of heart failure. It will enroll 200 participants who have both conditions. Half will receive a one-time procedure to electrically isolate the problematic heart veins, while the other half will receive standard drug therapy, to see which approach better prevents serious heart-related hospitalizations and events.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cardioangiologisches Centrum Bethanien

    RECRUITING

    Frankfurt am Main, 60431, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.